Your browser doesn't support javascript.
Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months.
Sahay, Rima R; Yadav, Pragya D; Nandapurkar, Ashok; Dhawde, Rutuja; Suryawanshi, Annasaheb; Patil, Deepak Y; Shete, Anita M; Sapkal, Gajanan N; Kulkarni, Milind; Gurav, Yogesh K; Deshpande, Gururaj R; Ghodke, Jagdevi S; Jain, Rajlaxmi; Hawale, Raj; Kalele, Kaumudi; Yemul, Jyoti; Gawande, Pranita; Abraham, Priya.
  • Sahay RR; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Yadav PD; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Nandapurkar A; Aundh Chest Hospital, Pimpri-Chinchwad, Pune, India.
  • Dhawde R; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Suryawanshi A; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Patil DY; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Shete AM; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Sapkal GN; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Kulkarni M; Aundh Chest Hospital, Pimpri-Chinchwad, Pune, India.
  • Gurav YK; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Deshpande GR; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Ghodke JS; Aundh Chest Hospital, Pimpri-Chinchwad, Pune, India.
  • Jain R; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Hawale R; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Kalele K; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Yemul J; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Gawande P; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Abraham P; Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India.
Hum Vaccin Immunother ; 18(7): 2156753, 2022 12 30.
Article in English | MEDLINE | ID: covidwho-2166142
ABSTRACT
We have evaluated the immunogenicity of two dose of Covaxin given at a one-month interval to two adult populations, i.e. COVID-19 naïve-vaccinated individuals (n = 118) and COVID-19 recovered individuals (n = 128) with the vaccination. The immune response in the study population were assessed at three follow-ups, namely at one month post first dose, one and six months after the second dose. The persistence of S1RBD IgG and neutralizing antibodies for six months post vaccination was observed at different time intervals. The enhanced immune response was observed in both the participant groups. The study emphasizes the need for a booster dose post six months of vaccination.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2022.2156753

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2022.2156753